Concepedia

Matthew Ho

MH

16

Publications

1.2K

Citations

13

H-Index

2017

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

University College Dublin

Mayo Clinic

Mayo Clinic in Arizona

Harvard University

Matthew Ho is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2023

16

Publications

16

Site-selective and versatile aromatic C−H functionalization by thianthrenation

Florian Berger, Matthew B. Plutschack, Julian Riegger et al. · Nature · 2019 · 688 citations

, ,

A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity

Jiye Liu, Tianyu Song, Wenrong Zhou et al. · Leukemia · 2018 · 79 citations

, , +11

Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling

Matthew Ho, Tianzeng Chen, Jiye Liu et al. · Leukemia · 2019 · 74 citations · Full text

A Protocol for Improved Precision and Increased Confidence in Nanoparticle Tracking Analysis Concentration Measurements between 50 and 120 nm in Biological Fluids

Martin Parsons, Damien McParland, Paulina B. Szklanna et al. · Frontiers in Cardiovascular Medicine · 2017 · 53 citations · Full text

Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma

Saurabh Zanwar, Matthew Ho, Yi Lin et al. · American Journal of Hematology · 2023 · 48 citations · Full text

Rows per page

1–5 of 16